You have 9 free searches left this month | for more free features.

Condition

ALL (1)

AML (1)

Acute Leukemia of Ambiguous Lineage (1)

Acute Myelogenous Leukemia (1)

Blood And Marrow Transplantation (1)

Relapsed/Refractory ALL (1)

Relapsed/Refractory AML (1)

Secondary AML/MDS (1)

Overall Status

Completed (2)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

M.D. Anderson Cancer Center (2)

Seattle Children's Hospital (1)

Collaborator

Children's Healthcare of Atlanta (1)

Genzyme, a Sanofi Company (1)

Pediatric Oncology Experimental Therapeutics Investigation Consortium (1)

Proteonomix, Inc. (1)

Intervention

plerixafor (2)

apheresis procedure (1)

clofarabine (1)

filgrastim (1)

plerixafor dose escalation (1)

Study Documents

Intervention Type

drug (3)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

Mobozil

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)

Terminated

Has Results

Acute Myelogenous Leukemia

Houston, Texas

University of Texas MD Anderson Cancer Center

Aug 19, 2019

Blood And Marrow Transplantation Trial in Houston (Filgrastim, Plerixafor, Apheresis Procedure)

Completed

Has Results

Blood And Marrow Transplantation

Filgrastim
+2 more

Houston, Texas

University of Texas MD Anderson Cancer Center

Apr 1, 2019

Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)

Completed

Relapsed/Refractory AML
+5 more

Plerixafor Dose Escalation

Phoenix, Arizona
+8 more

Sep 5, 2018